Pharma Tailor Made Services (PTMS), offers services to the pharmaceutical industry on a variety of fields, presents a different understanding to provide creative solutions.Taking into consideration the existing requirements of the pharma companies, PTMS produces individualized and unique solutions for each company.PTMS trainings and seminers  offers the opportunity to network with colleagues in pharmaceyitical area of business and PTMS seminars provide an interactive environment in which to learn about the latest regulations,  developments and give a different vision.

PTMS

Sr. Service executive

QA executive

Farmakovijilans Sorumlusu

chef

Physician

1st Engineer

Steward

high pressure water

Eğitmen - Eğitim Danışmanlık Koordinatörü

Business Unit Manager

Product Manager

Regional Manager

Chief IR/Bosun

Intergrated Rating

Lubication tech Shift coverage

Integrated Rating

Chief IR Crane OP Fugro Synergy

Rigger/Crane op

Rigger

GSO FPSO Four Rainbow

2nd cook

Outlook

Microsoft Office 365

GoDaddy Hosting

WordPress.org

Google Tag Manager

Typekit

Abdi İbrahim, Turkish pharmaceutical industry leader, was founded in 1912 in Küçükmustafapaşa, Istanbul at a small pharmacy, by Pharmacist Abdi Nadir İbrahim Bey who had started the "healing" journey. Abdi İbrahim has the largest product portfolio in the sector, with nearly 250 brands and more than 500 products which it develops itself as well as working with 30 licensors. With a powerful vision, dynamic structure and contemporary outlook, Abdi İbrahim has been the leader of Turkey's Pharmaceutical Industry since 2002. Today, Abdi İbrahim, which operates in 17 countries outside Turkey, exports to more than 70 countries ranging from Canada to European Union member states, from North Africa to Asia and creates the highest employment with nearly 5.500 qualified employees in the Turkish pharmaceutical industry. The company also comes to the fore with its marketing and sales team, which is the largest in the industry. Abdi İbrahim, having the first accredited R&D center in the industry, is a role model with its technological equipment and architecture as well as R&D processes in healing the future. Abdi Ibrahim has an R&D Center, production facility for chemical products, Turkey's largest biotechnological manufacturing facility AbdiBio and hormone production area, ophthalmology production area which will be operational in 2019 and Sterile Injectable & Oncology production facility which will be operational in 2021 in Istanbul Esenyurt production complex. Abdi İbrahim has also R&D Centers and production facilities in Kazakhstan and Algeria. Abdi İbrahim has taken an important step by signing United Nations Global Principles Agreement in 2010 and given the opportunity to share high standards which it has acquired in the fields of human rights, as well as environmental and social responsibility. Besides, Abdi İbrahim has focused its activities on sustainability studies on level A of Global Reporting Initiative (GRI) and published its third Sustainability Report.

Abdi Ibrahim Pharmaceuticals

Mobile Friendly

Bootstrap Framework

YouTube

bilim calisanlarının biraraya geldigi , resmi olmayan paylasım platformudur.Kurumu resmi olarak  temsil etmemektedir.non-official sharing platform...................................................................................................................................................................

Bilim Pharmaceuticals

Google Maps

ASP.NET

Microsoft-IIS

Google Analytics

Founded to serve health, Servier is a global group governed by a Foundation that aspires to have a meaningful social impact, both for patients and for a sustainable world. With its unique governance model, it can fully serve its vocation with a long-term vision: being committed to therapeutic progress to serve patient needs. The 21,900 employees of the Group are committed to this shared vocation, source of inspiration every day. As a world leader in cardiology, Servier's ambition is to become a focused and innovative player in oncology by targeting hard-to-treat cancers. That is why the Group allocates over 70% of its R&D budget to developing targeted and innovative therapies in oncology. Neuroscience and immuno-inflammatory diseases are the future growth drivers. In these areas, Servier is focused on a limited number of diseases in which accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote access to quality care for all at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, relying on strong brands in France, Eastern Europe, Brazil and Nigeria.In all these areas, the Group includes the patient voice at each stage of the life cycle of a medicine. Headquartered in France, Servier relies on a strong geographical footprint in over 150 countries and achieved a revenue of €4.3 billion in 2023.--To report a suspected adverse event with a Servier drug, please visit servier.com

Damla Cimen

Eğitmen - Eğitim Danışmanlık Koordinatörü at PTMS

Damla Cimen's Professional Contact Details

Damla Cimen's Current Company Details

PTMS

Damla Cimen's Work History and Education

Frequently Asked Questions about Damla Cimen

What company does Damla Cimen work for?

What is Damla Cimen's role at PTMS?

What is Damla Cimen's email address?

What is Damla Cimen's business email address?

What is Damla Cimen's HQ phone number?

What industry does Damla Cimen work in?

Who are Damla Cimen's colleagues?

Colleagues at PTMS

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?